Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: Implications for cardiovascular risk
Pablo Tebas, William Keith Henry, Roy Matining, Deborah Weng-Cherng, John Schmitz, Hernan Valdez, Nasreen Jahed, Laurie Myers, William G. Powderly, David Katzenstein
Dive into the research topics of 'Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: Implications for cardiovascular risk'. Together they form a unique fingerprint.